Bleached Corals “Sickest” Scientists Have Ever Seen

Researchers assess which parts of the Great Barrier Reef that have lost their vivid color are likely to die and which parts may pull through.

Written byChristie Wilcox, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

coral bleachingBleached colony of the soft coral bent sea rod WIKIMEDIA, KELSEY ROBERTS, USGSWith El Niño subsiding, Australian authorities are assessing the damage from this year’s bleaching event, which impacted an estimated 93 percent of the 3,000 or so reefs that comprise the Great Barrier Reef (GBR). “We’re in the tail-end period, where we’re waiting for the final mortality total to unfold,” Terry Hughes of the ARC Centre of Excellence for Coral Reef Studies at James Cook University told The Scientist at the International Coral Reef Symposium, which is ongoing this week in Honolulu, Hawaii.

And so far, the results are not looking good. “The corals we’re looking at are almost falling apart. They’re the sickest we’ve ever seen,” said Bill Leggat, associate professor with the ARC Centre of Excellence for Coral Reef Studies. “If we couple that with what we’re seeing with the visual surveys, with the number of corals impacted and the severity of the stress and the damage that we’re seeing, then it gets to be quite a scary story.”

When corals are stressed, they lose the symbiotic algae that live in their tissues, leading to a loss of color called bleaching. But not all the algae have to leave for the color to be lost; corals can bleach to different degrees, even if they look completely ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies